| Mark F Guilfoyle, DO | |
|
1 Medical Center Dr, Dartmouth Hitchcock - Radiology, Lebanon, NH 03756-1000 | |
| (603) 650-7650 | |
| Not Available |
| Full Name | Mark F Guilfoyle |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558329128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 5101009072 (Michigan) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 17059 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark F Guilfoyle, DO 1 Medical Center Dr, Dartmouth Hitchcock - Radiology, Lebanon, NH 03756-1000 Ph: (603) 650-7650 | Mark F Guilfoyle, DO 1 Medical Center Dr, Dartmouth Hitchcock - Radiology, Lebanon, NH 03756-1000 Ph: (603) 650-7650 |
News Archive
An experimental study has revealed that lovastatin, a drug prescribed for the treatment of hypercholesterolemia, protects animals against the deadly effects of plague. This infectious disease is on the upsurge in parts of the world. These results obtained by scientists at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (CNRS/Université Aix-Marseille 2) have been published in the journal PLoS ONE.
Physical and biological models often have hundreds of inputs, many of which may have a negligible effect on a model's response. Establishing parameters that can be fixed at nominal values without significantly affecting model outputs is often challenging; sometimes these parameters cannot be simply discerned by the outputs.
A lung transplant often remains the only option for many patients with end-stage lung disease, a condition that can be brought on by emphysema, pulmonary fibrosis, cystic fibrosis and other lung disorders.
Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced the closing of its previously announced sale of $30 million of shares of its Series 2 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to a single institutional investor. The investor has elected to convert all of its shares of Series 2 Preferred Stock and to receive the 18,853,103 shares of the Company's common stock issuable upon such conversion at the closing.
A new record for original science submissions has been set for the world's leading heart failure congress. In addition to the main abstract programme, highly anticipated results from major studies will be presented in the late breaking trial sessions.
› Verified 5 days ago
Thomas Ray Burdick, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
William B. Zucconi, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Thomas Francis Delaney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-6600 | |
Dr. Jessica Margaret Sin, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Dr. Harlan G Herr, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Matthew E Maeder, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-4371 | |
Dr. Judith Austin-strohbehn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Department Of Radiology, Lebanon, NH 03756 Phone: 603-650-4477 Fax: 603-650-5455 |